Maria C Carrillo, Bruno Vellas. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Alzheimer Disease/prevention & controlAntibodies, Monoclonal, Humanized/therapeutic useClinical Trials, Phase III as Topic/methodsHumansMulticenter Studies as Topic/methodsNootropic Agents/therapeutic useRandomized Controlled Trials as Topic/methods
Substances： See more » Antibodies, Monoclonal, HumanizedNootropic Agentssolanezumabbapineuzumab
Year: 2013 PMID： 23809363 DOI： 10.1016/j.jalz.2013.03.008
Source DB: PubMed Journal: Alzheimers Dement ISSN： 1552-5260 Impact factor: 21.566